Day One Biopharmaceuticals Balance Sheet (2022-2025) | DAWN

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 262.73M388.88M120.86M85.26M49.27M189.21M241.18M230.78M270.39M239.62M422.76M124.97M33.36M35.62M43.28M
Short-term Investments 253.48M257.01M268.91M253.67M164.36M135.56M47.55M122.25M135.62M406.75M439.66M417.48M408.30M
Cash & Current Investments 262.73M388.88M374.34M342.27M318.18M442.88M405.54M366.35M317.94M361.87M558.38M531.72M473.02M453.10M451.58M
Receivables - Net 9.14M8.70M13.88M18.05M19.67M16.70M
Receivables 9.14M8.70M13.88M18.05M19.67M16.70M
Work In Process 2.45M5.15M6.00M
Finished Goods 0.87M1.39M1.06M
Inventory 0.15M2.73M3.32M3.56M6.54M7.06M
Prepaid Assets 267.37M402.50M380.51M5.61M322.39M6.90M7.75M8.93M8.09M12.01M11.18M13.41M14.01M15.11M14.63M
Current Assets 347.87M449.78M413.29M375.27M326.03M383.16M581.00M562.33M508.65M494.43M489.97M
Non-Current Assets
Property, Plant & Equipment (Net) 0.07M0.07M0.04M0.02M0.07M0.18M0.21M0.21M0.18M0.20M0.90M2.29M2.51M2.32M2.23M
Intangibles 16.80M16.22M15.63M20.41M19.61M18.82M
Goodwill & Intangibles 16.80M16.22M15.63M20.41M19.61M18.82M
Other Non-Current Assets 0.17M0.48M0.45M0.47M0.49M0.26M0.23M0.21M0.17M0.12M0.12M0.12M0.21M0.18M0.32M
Non-Current Assets 1.19M0.97M0.89M0.77M0.61M17.28M19.81M20.46M25.70M24.61M23.81M
Assets 267.78M404.05M381.86M349.06M323.56M450.76M414.18M376.05M326.64M400.44M600.81M582.79M534.36M519.04M513.78M
Liabilities
Current Liabilities
Accounts Payables 0.70M0.44M3.97M15.95M4.66M4.57M3.39M2.58M4.78M6.44M3.02M3.26M2.54M5.09M5.78M
Payables 0.70M0.44M3.97M15.95M4.66M4.57M3.39M2.58M4.78M6.44M3.02M3.26M2.54M5.09M5.78M
Accumulated Expenses 7.30M11.93M13.84M15.95M17.77M19.52M20.65M26.52M24.76M87.07M35.19M68.62M43.64M44.13M48.21M
Other Accumulated Expenses 0.18M1.04M
Current Leases 0.17M0.43M0.46M0.41M0.42M0.43M0.44M0.41M0.30M0.19M0.08M0.01M0.06M0.15M0.16M
Current Deferred Revenue 1.46M1.55M1.64M1.85M2.32M
Total Current Liabilities 8.18M12.80M18.27M16.61M22.85M24.51M24.48M29.51M29.84M93.71M39.74M73.45M47.88M51.22M56.47M
Non-Current Liabilities
Non-Current Deffered Revenue 3.06M3.23M3.35M3.37M2.95M
Operating Leases 0.62M0.51M0.41M0.30M0.19M0.08M2.54M2.59M2.85M2.85M2.73M
Other Non-Current Liabilities 0.76M0.76M0.76M0.76M
Total Non-Current Liabilities 79.28M54.08M57.44M62.15M
Total Liabilities 8.18M13.42M18.79M17.02M23.15M24.70M24.55M29.51M29.84M93.71M45.34M80.04M54.84M58.20M62.91M
Shareholder's Equity
Common Equity 259.60M390.63M363.08M332.04M300.42M426.05M389.63M346.54M296.81M306.73M555.46M502.75M479.51M460.83M450.87M
Shareholder's Equity 259.60M390.63M363.08M332.04M300.42M426.05M389.63M346.54M296.81M306.73M555.46M502.75M479.51M460.83M450.87M
Liabilities and Shareholders Equity 267.78M404.05M381.86M349.06M323.56M450.76M414.18M376.05M326.64M400.44M600.81M582.79M534.36M519.04M513.78M
Retained Earnings -155.23M-191.76M-229.56M-269.67M-312.06M-357.92M-404.07M-458.58M-521.00M-525.40M-488.37M-554.08M-590.08M-620.40M-640.12M
Treasury Shares 0.39M0.43M0.44M0.49M0.92M0.95M0.95M0.95M2.24M1.92M1.89M1.77M2.86M2.96M2.76M